Market highlights
Factors such as developments in molecular imaging
technologies, growing consumer interest for non-invasive small-animal imaging
approaches, and growing R&D investments to support preclinical research are
slated to propel market growth. Preclinical micro-ultrasound technologies are
being investigated for developmental genetics, cancer , and cardiovascular
disease. The new advances in high-frequency ultrasonic imaging are still being
established with respect to the future. The use of multiple imaging modalities
for preclinical trials will help researchers understand the biological,
genetic, and physiological changes in living animals and forecast the outcome
of experimental therapies in patients. Consequently, the market is slated to
see strong growth over the forecast period due to both of these factors.
Furthermore, the steady pace of technological innovation that leads to the
production of hybrid imaging systems is primarily driving global market growth.
Moreover, the number of clinical research organizations (CROs) and
pharmaceutical firms is the use of in-vivo imaging systems in preclinical
testing, which accelerates further the development of this market.
Strict legislation in preclinical science, however, as well as
high deployment and maintenance costs associated with preclinical imaging
modalities impede market development over the poised period. In addition, the
limitations imposed on animal testing due to laws implemented by organisations
defending animal rights are the main factors impeding business development.
Segmental Analysis
The global preclinical imaging market has been analyzed based on the reagent, modality,
and region.
The modality-based segmentation of the market comprises into
optical imaging systems, nuclear imaging systems, micro-ultrasound, micro-MRI,
photoacoustic imaging, micro-CT, and magnetic particle imaging. The field of
optical imaging systems is predicted to continue its dominance over the market
share as it recorded in 2017.
The reagent-based segmentation of the market comprises
preclinical ultrasonic contrast agents, preclinical optical imaging reagents,
preclinical MRI contrast agents, preclinical nuclear imaging reagents, and
preclinical CT contrast agents. The field of preclinical optical imaging
reagents is predicted to maintain its winning streak over the prognosis period.
Competitive Dashboard
Some of the eminent players in the global preclinical imaging
market are Bruker Corporation (US), MR Solutions (UK), PerkinElmer Inc. (US),
Fujifilm Holdings Corporation (Japan), Milabs B.V. (The Netherlands), Mediso
Ltd. (Hungary), LI-COR, Inc. (US), Miltenyi Biotec GmbH (Germany), Aspect
Imaging (Israel), and Trifoil Imaging (US).
Regional Overview
The Asia-Pacific preclinical imaging market is consists of
developing economies like China, the Republic of Korea, India , Japan,
Australia, and the rest of the Asia-Pacific region. The Asia-Pacific region is
slated to be the region with the highest growth. the high demand for remote
sensing services in various applications, such as precision farming, 3D terrain
model building, damage evaluation, pipeline tracking, geohazard modeling,
resource extraction, and security and intelligence is leading the Asia Pacific
region market to secure the fastest CAGR.
Driven by growing investments in numerous military and
commercial satellite projects, North America is second to the European market
in the demand for remote sensing satellites. The North American industry is
powered primarily by an growing need for remote sensing services in diverse
industries and the presence of major public and private companies.
Europe is slated to hold the second-largest regional growth in
the global market for preclinical imaging. The growing success of this region's demand is resulting in
further R&D investments towards the promotion of preclinical research. On
the other hand, the Middle East & Africa is observing gradual growth and is
slated to acquire for the lowest market share of the preclinical imaging
market.
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting
Services. MRFR team have supreme objective to provide the optimum quality
market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research
and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
0 Comments